Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
Outlook Therapeutics enters into commercialization agreement with AmerisourceBergen
10:10am, Tuesday, 27'th Sep 2022
Outlook Therapeutics Inc (NASDAQ:OTLK) said it has entered into a strategic relationship with healthcare company AmerisourceBergen in preparation for the anticipated commercial launch in the United St
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
01:32pm, Monday, 26'th Sep 2022
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
AmerisourceBergen (ABC) to Buy Germany's PharmaLex for $1.3B
01:32pm, Tuesday, 13'th Sep 2022
AmerisourceBergen (ABC) inks a deal to acquire PharmaLex to support its goal to become a strategic partner of choice for pharma customers for clinical and commercial enablement solutions.
AmerisourceBergen agrees to acquire Germany's PharmaLex for 1.28 billion euros in cash
08:23am, Monday, 12'th Sep 2022
AmerisourceBergen Corp. ABC, -0.18% said Monday it has agreed to acquire PharmaLex Holding GmbH, a German company offering specialized services for the life sciences industry, or 1.28 billion euros ($
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
12:47pm, Wednesday, 24'th Aug 2022
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Is WBA Stock A Buy Or Sell After Pivotal Court Ruling In Opioids Case?
07:36am, Friday, 19'th Aug 2022
Walgreens faces legal challenges as rising costs eat into profit margins. Is Walgreens stock a buy?
Back To The Future With AmerisourceBergen Corporation
11:50am, Tuesday, 16'th Aug 2022
ABC has recently pulled back and provides a potential entry point for investors. Long term, the industry should maintain its 1% share of US expenditure on pharmaceuticals. The Inflation Reduction Act
Is AmerisourceBergen (ABC) a Solid Growth Stock? 3 Reasons to Think "Yes"
02:18pm, Monday, 15'th Aug 2022
AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market.
Beat the Market the Zacks Way: Walt Disney (DIS), AmerisourceBergen (ABC), C.H. Robinson Worldwide (CHRW) in Focus
06:01am, Monday, 15'th Aug 2022
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.
Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year?
11:17am, Wednesday, 10'th Aug 2022
Here is how AmerisourceBergen (ABC) and Aerie Pharmaceuticals (AERI) have performed compared to their sector so far this year.
Are Investors Undervaluing AmerisourceBergen (ABC) Right Now?
11:17am, Wednesday, 10'th Aug 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
10 defensive stocks that can also provide you with growth and dividends over the long term
10:05am, Wednesday, 10'th Aug 2022
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
AmerisourceBergen (ABC) Q3 Earnings & Revenues Top Estimates
12:47pm, Wednesday, 03'rd Aug 2022
AmerisourceBergen's (ABC) fiscal third-quarter results benefit from segmental growth.
Amerisourcebergen Corp (ABC) CEO Steven Collis on Q3 2022 Results - Earnings Call Transcript
11:51am, Wednesday, 03'rd Aug 2022
Amerisourcebergen Corp (NYSE:ABC ) Q3 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants Bennett Murphy - SVP, IR Steven Collis - Chairman, President & CEO James Cleary - EVP
AmerisourceBergen (ABC) Q3 Earnings and Revenues Surpass Estimates
09:02am, Wednesday, 03'rd Aug 2022
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.95% and 1.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
